Stocks TelegraphStocks Telegraph
Stock Ideas

CTLT Company Profile and Key Details

NYSE : CTLT

Catalent, Inc.

$63.48
0-
At Close 4:00 PM
Not Actively Trading
62.09
B+ESG ScoreESG Rating

CTLT Stock Price Chart

Stock Price Today

Catalent, Inc. (CTLT) stock remained unchanged at $63.48 a share on NYSE. The stock opened at $63.49, fluctuating between $63.44 to $63.50 during the session.

Stock Snapshot

63.48
Prev. Close
63.49
Open
11.52B
Market Cap
181.51M
Number of Shares
63.44
Day Low
63.5
Day High
-27.842105263157894
P/E Ratio
99.37%
Free Float in %
-2.28
EPS (TTM)
20.26
Book Value
-1.45
Cash Flow per Share
13.67M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Dec 17, 202463.4963.5063.4463.498.08M
Dec 16, 202463.4863.4963.4763.487.13M
Dec 13, 202463.0663.1663.0263.071.15M
Dec 12, 202463.0863.2363.0363.071.54M
Dec 11, 202462.5063.2562.2363.247.73M
Dec 10, 202462.5062.5062.2162.242.13M
Dec 09, 202461.8562.3761.8562.372.87M
Dec 06, 202461.9062.1661.7261.832.71M
Dec 05, 202462.1962.2061.8862.123.03M
Dec 04, 202461.7561.9761.5261.841.8M
Dec 03, 202461.4362.0861.1861.704.22M
Dec 02, 202460.9461.4860.8161.451.52M
Nov 29, 202461.0061.2160.9161.11771.2K
Nov 27, 202460.9561.0560.7061.001.5M
Nov 26, 202461.2861.2960.7560.751.94M
Nov 25, 202460.9861.3060.9461.292.64M
Nov 22, 202459.9061.5059.8260.984.87M
Nov 21, 202459.0959.8458.9259.661.19M
Nov 20, 202458.7259.0558.6859.001.64M
Nov 19, 202458.5158.9858.3958.881.1M

Contact Details

Somerset, NJ 08873

United States

Website: https://www.catalent.comContact: 732 537 6200

About Company

Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral based gene therapy; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services. The Clinical Supply Services segment offers manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials. It also offers FastChain demand-led clinical supply services. The company serves pharmaceutical, biotechnology, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. Catalent, Inc. was incorporated in 2007 and is headquartered in Somerset, New Jersey.

Company Information

Employees17000
Beta1.16
Sales or Revenue$4.38B
5Y Sales Change%0.258%
Fiscal Year EndsJune
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Frequently Asked Questions

What is the current Catalent, Inc. (CTLT) stock price?

Catalent, Inc. (NYSE: CTLT) stock price is $63.48 in the last trading session. During the trading session, CTLT stock reached the peak price of $63.50 while $63.44 was the lowest point it dropped to. The percentage change in CTLT stock occurred in the recent session was 0% while the dollar amount for the price change in CTLT stock was -.

CTLT's industry and sector of operation?

The NYSE listed CTLT is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Catalent, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CTLT?

Mr. Paul Surdez
Vice President of Investor Relations
Mr. John R. Chiminski
Executive Chair of the Board
Dr. Aristippos Gennadios Ph.D.
Group Pres of Pharma & Consumer Health Segment
Mr. Joseph A. Ferraro J.D.
Senior Vice President, Gen. Counsel, Chief Compliance Officer & Sec.
Mr. Alessandro Maselli
Pres, Chief Executive Officer & Director
Mr. Ricky Hopson
Pres and Division Head for Clinical Devel. & Supply
Mr. Steven L. Fasman Esq.
Executive Vice President, Corporation Sec. & Chief Admin. Officer
Mr. Matti M. Masanovich
Senior Vice President & Chief Financial Officer
Ms. Lisa Evoli
SVice President & Chief HR Officer
Mr. Thomas P. Castellano
Senior Vice President & Chief Financial Officer
Ms. Karen Murphy Santiago
Vice President & Chief Accounting Office
Mr. Julien Meissonnier
Vice President & Chief Scientific Officer
Mr. Charles Lickfold
Senior Vice President & Chief Information Officer
Mr. Michael J. Grippo
Senior Vice President of Strategy & Corporation Devel.
Mr. Ricardo Pravda
Senior Vice President & Chief HR Officer

How CTLT did perform over past 52-week?

CTLT's closing price is 50.75% higher than its 52-week low of $42.11 where as its distance from 52-week high of $63.50 is -0.03%.

How many employees does CTLT have?

Number of CTLT employees currently stands at 17,000.

Link for CTLT official website?

Official Website of CTLT is: https://www.catalent.com

How do I contact CTLT?

CTLT could be contacted at phone 732 537 6200 and can also be accessed through its website. CTLT operates from 14 Schoolhouse Road, Somerset, NJ 08873, United States.

How many shares of CTLT are traded daily?

CTLT stock volume for the day was 13.67M shares. The average number of CTLT shares traded daily for last 3 months was 2.27M.

What is the market cap of CTLT currently?

The market value of CTLT currently stands at $11.52B with its latest stock price at $63.48 and 181.51M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph